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Background: The physiologic processes of mitochondrial (MITO) biogenesis, fission and fusion are abnormal in the failing heart and can result in 
MITO hyperplasia, reduced size and poor respiration. This study examined the regulation of two key MITO proteins; porin (PO), the outer membrane 
protein that forms the aqueous channel for metabolite flux between mitochondria and cytosol, and mitofilin (MF), a key player in maintaining MITO 
cristae morphology and is indispensible for normal MITO function.
Methods: SDS-extract was prepared from LV tissue of 6 explanted failed human hearts due to ischemic cardiomyopathy (ICM), 6 failed hearts due 
to idiopathic dilated cardiomyopathy (IDC), and 6 normal donor (DNR) hearts and from LV of 6 dogs with microembolization-induced heart failure 
(HF) and 6 normal (NL) dogs. Protein level was measured with Western blotting and band intensity quantified in densitometric units and normalized 
to the house keeping protein glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Results: Protein levels of PO did not change in LV of HF humans or dogs compared to normals. MF protein levels, however, were significantly 
reduced in ICM and IDC human hearts compared to DNR hearts and in HF dogs compared to NL dogs (Table).
Conclusions: Downregulation of the key MITO protein MF in LV myocardium of failing human and dog hearts provides support to the concept of 
energy deprivation in HF and emphasizes the need for developing therapeutics that target this key abnormality.
Protein Expression in LV Myocardium
Dog Human
NL HF DNR ICM DCM
PO/GAPDH 0.41 ± 0.02 0.38 ± 0.02 0.24 ± 0.02 0.25 ± 0.01 0.25 ± 0.01
MF/GAPDH 0.75 ± 0.01 0.29 ± 0.02* 0.26 ± 0.02 0.12 ± 0.01† 0.10 ± 0.01†
*=p<0.05 vs. NL; †= p<0.05 vs. DNR
